Age-dependent prevalence of vascular disease-associated polymorphisms among 2689 volunteer blood donors

Clinical Chemistry

Volumn 47, Issue 10, 2001, Pages 1879-1884

  Hessner, M J ^a   Dinauer, D M ^a   Kwiatkowski, R ^a   Neri, B ^a   Raife, T J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; DIPEPTIDYL CARBOXYPEPTIDASE; GLYCOPROTEIN; GLYCOPROTEIN IIIA; PROTHROMBIN;

ADOLESCENT; ADULT; AGE; AGED; ALLELE; BLOOD DONOR; CAUCASIAN; CONFERENCE PAPER; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; INTRON; LONGEVITY; MALE; NORMAL HUMAN; PREVALENCE; VASCULAR DISEASE;

EID: 0034827541     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.10.1879     Document Type: Conference Paper

References (42)

1. Familial thrombophilia due to a previously unrecognized mechanism characterized by a poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
2. Resistance to activated protein C as a basis for venous thrombosis
3. Mutation in blood coagulation factor V associated with resistance to activated protein C
4. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR
5. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis
6. High risk of thrombosis in patients homozygous for factor V Leiden (APC resistance)
7. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with increased plasma prothrombin levels and an increase in venous thrombosis
8. The prothrombin G20210A variant: Prevalence in a U.K. anticoagulant clinic population
9. The 20210A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis
10. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease
11. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
12. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease
13. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease
14. Homocyst(e)ine and arterial occlusive diseases
15. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
16. Risk of venous thrombosis in carriers of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductase
17. 2 gene coding sequence
18. 2 gene coding sequence T807/A873 of the platelet collagen receptor integrin might be a genetic risk factor for the development of stroke in young patients
19. Association of two silent polymorphisms of platelet glycoprotein la/lia receptor with risk of myocardial infarction: A case-control study
20. Association of the platelet glycoprotein 1a C807T gene polymorphism with nonfatal myocardial infarction in younger patients
21. Allelic distribution of the glycoprotein 1a (α2-integrin) C807T/G873A dimorphism among Caucasian venous thrombosis patients and six racial groups
22. Molecular genetics of the renin-angiotensin system: Implications for angiotensin II receptor blockade
23. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half of the variance of serum enzyme levels
24. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidyl carboxypeptidase 1)
25. Angiotensin I-converting enzyme: Genotype and disease associations
26. The human platelet aloantigens, PIA1 and PIA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing
27. 3 enhances outside-in signaling and adhesive functions
28. A2 polymorphisms display different sensitivities to agonists
29. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis
30. Integrin polymorphisms as risk factors for thrombosis
31. Genotyping of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes
32. Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers
33. Factor V. Leiden and thermolabile methylenetetrahydrofolate reductase in extreme old age
34. The prothrombin 20210GA genotype acts as a cooperative risk factor for venous thrombosis among factor V 1691GA (Leiden) carriers
35. Methylenetetrahydrofolate reductase thermolabile variant and human longevity
36. Longevity is independent of common variations in genes associated with cardiovascular risk
37. The frequency of the methylenetetrahydrofolate reductase-gene mutation varies with age in the normal population
38. ACE gene polymorphism: Ischemic heart disease and longevity in 10,150 individuals. A case referent and retrospective cohort study based upon the Copenhagen City Heart Study
39. Genetic associations with human longevity at the APOE and ACE loci
40. Typing for human platelet alloantigens
41. A polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation
42. The platelet PIA2 and ACE D allele polymorphisms are synergistic for the risk of recurrent events in patients post myocardial infarction and pravastatin reduces the risk